These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35207580)

  • 1. Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy.
    Johansson M; Ulfenborg B; Andersson CX; Heydarkhan-Hagvall S; Jeppsson A; Sartipy P; Synnergren J
    Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac hypertrophy in a dish: a human stem cell based model.
    Johansson M; Ulfenborg B; Andersson CX; Heydarkhan-Hagvall S; Jeppsson A; Sartipy P; Synnergren J
    Biol Open; 2020 Sep; 9(9):. PubMed ID: 32878883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Protein Kinase C Modulators Reveal a Pro-hypertrophic Role for Novel Protein Kinase C Isoforms in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Pohjolainen L; Easton J; Solanki R; Ruskoaho H; Talman V
    Front Pharmacol; 2020; 11():553852. PubMed ID: 33584253
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes.
    Uesugi M; Ojima A; Taniguchi T; Miyamoto N; Sawada K
    J Pharmacol Toxicol Methods; 2014; 69(2):177-88. PubMed ID: 24296355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data Mining Identifies
    Johansson M; Tangruksa B; Heydarkhan-Hagvall S; Jeppsson A; Sartipy P; Synnergren J
    Life (Basel); 2022 May; 12(5):. PubMed ID: 35629393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.
    Aggarwal P; Turner A; Matter A; Kattman SJ; Stoddard A; Lorier R; Swanson BJ; Arnett DK; Broeckel U
    PLoS One; 2014; 9(9):e108051. PubMed ID: 25255322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 influences mechanical properties and contractility of hiPSC derived cardiomyocytes resulting in diastolic dysfunction.
    Redwanz C; Pires RH; Biedenweg D; Groß S; Otto O; Könemann S
    J Mol Cell Cardiol; 2024 Jul; 194():105-117. PubMed ID: 39019395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset.
    Mournetas V; Massouridès E; Dupont JB; Kornobis E; Polvèche H; Jarrige M; Dorval ARL; Gosselin MRF; Manousopoulou A; Garbis SD; Górecki DC; Pinset C
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):209-232. PubMed ID: 33586340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic and Glyco(proteo)mic tools in the profiling of cardiac progenitors and pluripotent stem cell derived cardiomyocytes: Accelerating translation into therapy.
    Sebastião MJ; Marcos-Silva L; Gomes-Alves P; Alves PM
    Biotechnol Adv; 2021; 49():107755. PubMed ID: 33895330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase.
    Parreira RC; Gómez-Mendoza DP; de Jesus ICG; Lemos RP; Santos AK; Rezende CP; Figueiredo HCP; Pinto MCX; Kjeldsen F; Guatimosim S; Resende RR; Verano-Braga T
    Proteomics Clin Appl; 2020 Jul; 14(4):e2000017. PubMed ID: 32506788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes.
    Tang L; Yao F; Wang H; Wang X; Shen J; Dai B; Wu H; Zhou D; Guo F; Wang J; Li T; Wang H; Gong T; Su J; Wang L; Liang P
    J Mol Cell Cardiol; 2019 Jan; 126():143-154. PubMed ID: 30423318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
    Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
    J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell Transcriptomics of Engineered Cardiac Tissues From Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome.
    Lam YY; Keung W; Chan CH; Geng L; Wong N; Brenière-Letuffe D; Li RA; Cheung YF
    J Am Heart Assoc; 2020 Oct; 9(20):e016528. PubMed ID: 33059525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF Contributes to Mesenchymal Stem Cell-Mediated Reversion of Nor1-Dependent Hypertrophy in iPS Cell-Derived Cardiomyocytes.
    Philipp D; Holthaus M; Basoah V; Pfannkuche K; Suhr L; Wahlers T; Paunel-Görgülü A
    Stem Cells Int; 2021; 2021():8888575. PubMed ID: 33927770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats.
    Chowdhury D; Tangutur AD; Khatua TN; Saxena P; Banerjee SK; Bhadra MP
    J Transl Med; 2013 May; 11():130. PubMed ID: 23706090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data.
    Holmgren G; Sartipy P; Andersson CX; Lindahl A; Synnergren J
    Toxicol Sci; 2018 May; 163(1):182-195. PubMed ID: 29385562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
    Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
    Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.